CHIMERIC THERAPEUTICS LIMITED — Capital/Financing Update 2024

Jan 4, 2024

ASX ANNOUNCEMENT

5 January 2024

==> picture [262 x 53] intentionally omitted <==

Notice Under Section 708A(5)(e) of the Corporations Act 2001

This notice is given by Chimeric Therapeutics Limited (ASX: CHM) (‘Company’) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the Corporations Act).

Type	Shares
Class/description	Ordinary
ASX code	CHM
Date of issue	5 January 2024
Number issued	1,178,571

The Company gives notice pursuant to section 708A(5)(e) of the Corporations Act that:

1. the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act;

2. as at the date of this notice, the Company has complied with:

   • (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

   • (ii) sections 674 and 674A of the Corporations Act; and

3. as at the date of this notice, there is no information to be disclosed which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.

Nathan Jong Joint Company Secretary

Chimeric Therapeutics Limited ABN 68 638 835 828 www.chimerictherapeutics.com